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Abstract
Virus infections can result in a range of cellular injuries and commonly this involves both the plasma and intracellular
membranes, resulting in enhanced permeability. Viroporins are a group of proteins that interact with plasma membranes
modifying permeability and can promote the release of viral particles. While these proteins are not essential for virus
replication, their activity certainly promotes virus growth. Progressive multifocal leukoencephalopathy (PML) is a fatal
demyelinating disease resulting from lytic infection of oligodendrocytes by the polyomavirus JC virus (JCV). The genome of
JCV encodes six major proteins including a small auxiliary protein known as agnoprotein. Studies on other polyomavirus
agnoproteins have suggested that the protein may contribute to viral propagation at various stages in the replication cycle,
including transcription, translation, processing of late viral proteins, assembly of virions, and viral propagation. Previous
studies from our and other laboratories have indicated that JCV agnoprotein plays an important, although as yet
incompletely understood role in the propagation of JCV. Here, we demonstrate that agnoprotein possesses properties
commonly associated with viroporins. Our findings demonstrate that: (i) A deletion mutant of agnoprotein is defective in
virion release and viral propagation; (ii) Agnoprotein localizes to the ER early in infection, but is also found at the plasma
membrane late in infection; (iii) Agnoprotein is an integral membrane protein and forms homo-oligomers; (iv) Agnoprotein
enhances permeability of cells to the translation inhibitor hygromycin B; (v) Agnoprotein induces the influx of extracellular
Ca
2+; (vi) The basic residues at amino acid positions 8 and 9 of agnoprotein key are determinants of the viroporin activity.
The viroporin-like properties of agnoprotein result in increased membrane permeability and alterations in intracellular Ca
2+
homeostasis leading to membrane dysfunction and enhancement of virus release.
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Introduction
Replication of viruses involves an extracellular step in the viral
life cycle, involving the release of virus particles from infected cells
and subsequent infection of target cells. Most non-enveloped
viruses exit their host cells by lytic process, which involves
breakdown of the cell membrane and is associated with cell death
[1].
JC virus (JCV) is the causative agent of progressive multifocal
leukoencephalopathy (PML), and belongs to the family of
polyomaviruses, which also includes simian virus 40 (SV40) and
BK virus (BKV). Polyomaviruses have non-enveloped icosahedral-
shaped capsids of about 40 nm in diameter. It has been previously
suggested that extracellular exit of the mature progeny virions of
SV40 and JCV, which efficiently proliferate in the nuclei, occurs
when cells disintegrate or rupture as part of their dying process.
However, it remains unclear whether these virions employ specific
molecular mechanism(s) which may contribute to or regulate cell
lysis. Cell lysis is presumably the ultimate result of an increase in
plasma membrane permeability [2]. It has long been considered
that either the bulk of viral gene expression or the formation and
accumulation of progeny virus particles may be responsible for
enhancing membrane permeability and lysis of the cell. However,
more recent studies have suggested that individual viral proteins
may contribute to the enhancement of plasma membrane
permeability and release of progeny virions of a number of non-
enveloped viruses, including poliovirus, rotavirus, and coxsackie-
virus [3] [4] [5] [6] [7]. It has been shown that several viral
proteins with membrane permeabilizing properties share common
characteristics and these proteins have been named ‘‘viroporins’’
[6]. The proteins share a number of features in structure and
function. Viroporins are integral membrane proteins which vary in
size from about 60–120 amino acids, possessing at least one
hydrophobic stretch able to form an amphipatic a-helix.
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ions and other small molecules [2] [6]. After their insertion into
membranes, viroporins tend to oligomerize to create a hydrophilic
pore [8] [9] [10] [11], and these activities result in release of
progeny virions.
T h el a t ec o d i n gr e g i o no fJ C Ve n c o d e sas m a l la n db a s i c
regulatory protein, agnoprotein, whose functions in the virus life
cycle remains unclear. Studieso nt h eS V 4 0a g n o p r o t e i nh a v e
suggested that the protein may contribute to viral replication at
various stages including transcription, translation, and process-
ing of late viral proteins [12] [13] [14] [15], assembly of virions
[16] [17] [14], and viral propagation [18] [19]. Agnoprotein has
been shown to localize to the cytoplasmic and perinuclear
regions in infected cells [20], whereas the other viral proteins
are exclusively expressed in the nuclei [21] [20]. Recent
observations also suggest that JCV agnoprotein may be involved
in release of progeny virions and promote the propagation of
JCV [22] [23] [24]. Furthermore, a small interfering RNA
(siRNA) specific for agnoprotein mRNA was found to inhibit
JCV infection [25] [26].
In the present study, we have investigated the role of the JCV
agnoprotein in virion release. Comprising some 71 amino acids,
agnoprotein has a hydrophobic transmembrane domain that
interacts with and expands the lipid bilayer as homo-oligomers.
Furthermore, we have found that agnoprotein acts as a viroporin
and its expression induced plasma membrane permeabilization
and promoted JCV progeny virion release.
Results
An Agnoprotein Deletion Mutant Has a Defect in Virion
Release and Viral Propagation
Agnoprotein plays critical roles in viral propagation at multiple
steps in JC virus replication [27] [22] [23] [24]. Therefore, we
compared the propagation properties of an agnoprotein deletion
mutant (DAgno) virus with those of the wild type (WT) virus by
using a JCV growth assay, which is an established method for
measurement of JCV infectivity [28] [24]. In the DAgno mutant,
the translation initiation codon (ATG) was replaced with the stop
codon (TAA), and the mutant does not produce agnoprotein. VP1
protein of cells transfected with DAgno mutant was localized in the
nuclei similar to that of WT Agno transfected cells (Figure S1) at 4
days after transfection, suggesting that agnoprotein did not affect
the intracellular localization of VP1 at this time point. Although
the percentage of VP1 of JCV positive cells transfected with either
WT or DAgno mutant was similar at 4 days after transfection, the
percentage of VP1 positive cells transfected with DAgno mutant
was significantly lower than that of WT at 9 days after transfection
(Figure 1A), suggesting that the viral propagation was inhibited in
the absence of agnoprotein and which is in accordance with
previous reports [27] [25] [24]. We also found that the expression
level of VP1 in the culture supernatant from the cells transfected
with DAgno mutant was substantially decreased compared to that
of WT (SUP in Figure 1B). Together, these observations show that
agnoprotein plays an important role in the release of virions from
infected cells.
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Figure 1. Agnoprotein facilitates virion release and enhances
viral propagation. (A) The agnoprotein deletion mutant virus
(DAgnoJCV) fails to promote viral propagation. Viral growth was
monitored by indirect immunofluorescence of VP1. Results shown in
the graph were created by determining the average proportion of VP1-
positive cells in 3 to 10 microscopy fields counted. Significance of
changes were analyzed by student’s t-test and indicated by an asterisk
(*p,0.001). (B) Agnoprotein deletion mutant virus (DAgnoJCV) fails to
release the virions. Whole cell lysates (WCL) and culture supernatants
(SUP) from SVG-A cells transfected with wtJCV or DAgnoJCV at the
indicated days post-transfection were analyzed by immunoblotting
with anti-VP1, anti-agnoprotein and anti-actin antibodies. Culture
supernatants were concentrated to 25 times by centrifuging. Agnopro-
tein expression was confirmed by immunoblotting.
doi:10.1371/journal.ppat.1000801.g001
Author Summary
Most non-enveloped viruses exit their host cells following
cell lysis, which involves breakdown of the cell membrane
and death of the host cell, and which is presumably the
final result of an increase in plasma membrane permeabil-
ity. JC virus (JCV) is the causative agent of progressive
multifocal leukoencephalopathy (PML) and belongs to the
polyomavirus family, which have non-enveloped virions.
The extracellular release of mature progeny polyomavirus
virions has been suggested to occur when cells disinte-
grate or rupture; however, the molecular mechanism(s)
employed by JCV to induce cell lysis and facilitate virion
release remain elusive. Viroporins are a group of proteins
that modify the permeability of cellular membranes and
promote the release of viral particles from infected cells.
These proteins are not essential for the replication of
viruses, but their presence often enhances virus growth.
Here, we demonstrate that the JCV agnoprotein forms
homo-oligomers as an integral membrane protein and acts
as a viroporin, and that expression of agnoprotein results
in plasma membrane permeabilization and virion release.
These observations suggest that the process of virion
release of this non-enveloped DNA virus is highly
regulated by a single viral protein.
Viroporin Properties of JCV Agnoprotein
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Previously, we reported that agnoprotein is mainly localized in
the cytoplasm and perinuclear regions of JCV infected cells [27]
[20] [23]. To delineate in more detail the intracellular localization
of agnoprotein, we performed immunofluorescence studies using
human fetal glial SVG-A cells infected with JCV at 3 days after
infection. Confocal microscopy revealed that agnoprotien immu-
noreactivity was present in the perinuclear region and extended
into the cytoplasm in a mesh-like pattern (Figure 2A and S1).
Although its localization was relatively heterogenous, most of the
agnoprotein consistently overlapped with that of calreticulin, an
ER marker and specifically in the peripheral regions of the
cytoplasm (Figure 2A). We also performed iodixanol density
gradient analysis of the membrane fraction of JCV-infected IMR-
32 cells. In contrast to other JCV encoded proteins, such as VP1
and Large T antigen, agnoprotein and BiP, which is an ER
marker, were detected in the same fractions (Figure 2B), suggesting
that agnoprotein predominantly localizes at the ER. We next
examined the intracellular-localization of agnoprotein at various
time after infection. It could be shown that almost all agnoprotein
was distributed at the ER at 2 days after infection, which is
designated as an ER pattern (Figures 2A and C). However, at the
later stages (at 5 days after infection) of infection the localization of
agnoprotein in the ER changed to become more diffusely localized
in the cytoplasm (Figures 2C and D) (designated as diffuse pattern).
These observations suggested that while agnoprotein originally
localizes at the ER, it’s intracellular localization changes to involve
other intracellular compartments in time-dependent manner.
Agnoprotein is an Integral Membrane Protein and
Localizes at Plasma Membrane
Next, we attempted to define in more detail the properties of
agnoprotein. Analysis of subcellular fractions of 293AG cells which
are agnoprotein-inducible cell lines with doxycycline (DOX)
treatment [22] showed that agnoprotein was mainly detected in
the microsomal compared with the cytosol fractions (Figure 3A).
We then examined the interaction between agnoprotein and
microsomes by treatment of the microsome membrane fractions
with various chemical reagents that selectively disrupt interactions
on the surface without extracting proteins from phospholipids
bilayers (Figure 3B). Treatments with high salt concentration (1 M
KCl) and sodium carbonate buffer (pH 11), as well as incubation
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Figure 2. Agnoprotein localized at the ER. (A) Agnoprotein localizes in the ER. Confocal microscopy showed the colocalization of agnoprotein
(Agno) and Calreticulin (ER marker) in JCV infected SVG-A cells. The boxed areas in the upper panel are shown at higher magnification in the lower
panel. (B) The dominant co-localization of agnoprotein and BiP (ER marker) in JCV infected cells was shown by iodexanol density gradient analysis. (C
and D) The intracellular localization of agnoprotein was analyzed at various times after infection by confocal microscopy. Almost all agnoprotein
distribute as the ER pattern (C left panel), and there were a few cells with the diffuse pattern (C right panel) at the early stages of infection. The
percentage of cells with the diffuse pattern was found to increase in a time-dependent manner (D). Scale bars, 10 mm.
doi:10.1371/journal.ppat.1000801.g002
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Figure 3. Agnoprotein also localizes at the plasma membranes as an integral membrane protein. (A) Homogenates from 293AG
cells which are agnoprotein-inducible cell lines with doxycycline (DOX) treatment were subjected to subcellular fractionation as described in the
Materials and Methods. The cytosolic and microsomal fractions were analyzed by immunoblot analysis using antibodies to agnoprotein, calnexin
(ER marker), BiP (ER marker), and a-tubulin (cytosolic marker). (B) Microsomes were incubated for 30 min on ice with homogenization buffer
alone (2), or with buffer containing 1 M KCl, or 2 M urea. The microsomes were also treated with buffer containing 0.2 M sodium carbonate
(pH 11.0). Following treatment, the microsomes were separated into supernatant (S) and pellet (P) fractions by ultracentrifugation. (C)
Microsomes were also subjected to Triton X-114 phase separation, and aqueous phase (A, lane 1), detergent phase (D, lane 2), and insoluble
aggregates (P, lane 3) were obtained. (D and E) HeLa (D) and SVG-A (E) cells were transfected with pERedNLS-Agno or control vectors. Cell
surface agnoprotein on living cells was detected by incubation with antibody against the agnoprotein C-terminal region, followed by staining
with Alexa 488-labeled anti-rabbit IgG antibody. DsRed signals in the nuclei represent a marker of transfection. (F) Flow cytometry analysis of
cell surface expression of agnoprotein in 293T cells transfected with pCXSN-Agno (WT, left panel) orv e c t o rc o n t r o l( M o c k ,r i g h tp a n e l ) .T h eb l a c k
solid line represents anti-agnoprotein antibody staining and the light gray shade represents control rabbit IgG staining, followed by staining
with FITC-labeled anti-rabbit IgG antibody.
doi:10.1371/journal.ppat.1000801.g003
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which has no hydrophobic transmembrane domain (Figure 3B,
lower panel). In contrast, agnoprotein and calnexin, which have a
hydrophobic transmembrane domain, were not removed from the
microsome membrane even in the presence of these reagents
(Figure 3B, upper and middle panels) suggesting that agnoprotein
is embedded within the lipid bilayer. Consistent with this,
agnoprotein was recovered in the detergent phase along with
calnexin in the phase separation experiments using Triton X-114
[29] [30] (Figure 3C). As previously shown the intracellular
localization of agnoprotein changes in time-dependent manner
(Figures 2C and D). The anterograde transit of vesicular proteins
within the early secretory pathway is known to connect the ER to
plasma membrane trafficking [31]. To determine if agnoprotein is
involved in the secretory pathway, we examined the steady-state
cell surface expression of agnoprotein. Non-permeabilized HeLa
cells transfected with WTAgno were subjected to immunofluores-
cence staining with antibody which recognizes the agnoprotein C-
terminus [20]. Agnoprotein was detected at the plasma mem-
branes of both non-permeabilized HeLa (Figure 3D) and SVG-A
(Figure 3E) cells. The steady-state cell surface expression of
agnoprotein was further supported by flow cytometry studies
(Figure 3F). These observations suggested that agnoprotein is in
part co-translationally inserted into the ER membrane and
transported to the plasma membrane at the later stage of infection
with the C-terminus of agnoprotein at the extracellular surface.
The N-terminal Region of Agnoprotein is Necessary for
Targeting the ER
We next sought to identify the motif(s) of agnoprotein which are
necessary for targeting the ER. A Kyte and Doolittle hydropho-
bicity plot of agnoprotein revealed that the middle region of
agnoprotein contains the only hydrophobic region. This is
comprised of 18 amino acids and would serve as a potential
transmembrane segment (Figure 4A). To determine the domain of
agnoprotein important for its ER distribution, we generated a
series of mutants as fusion proteins with the GST-EGFP tag
(,50 kDa) (Figure 4B). Immunoblot analyses of GST-EGFP–
fused agnoprotein and its mutants were prepared from the ER-
nuclear fraction of transfected HEK293 cells by sucrose density
centrifugation. WT and N46 mutant were detected in the ER-rich
fractions, but the C6 mutant and GST-EGFP were not (Figure 4C).
This result suggested that the N-terminus of agnoprotein was
necessary for targeting to the ER.
Both the Basic Amino Acid Cluster and Hydrophobic
Regions of Agnoprotein are Required for ER Targeting
We have demonstrated that agnoprotein has an extracellular
carboxyl terminal (C-terminal) domain (Figures 3D, E, and F) and
that the N-terminal region of agnoprotein was important for the
ER targeting (Figure 4C). These results suggest that agnoprotein
might have a cytoplasmic domain at the amino terminus and
should be considered as an integral transmembrane protein type II
[32]. In this situation positively charged amino acids at the N-
terminal region would be important for determining the
orientation of the transmembrane segment [33]. Agnoprotein
has some basic residues in the N-terminal 24 amino acids, and to
determine the residues responsible for the subcellular localization
of agnoprotein, amino acid point mutations of agnoprotein where
generated by site-directed mutagenesis (Figure S3), and the
subcellular localizations in 293T cells transiently transfected with
these constructs and pDsRed-ER were analyzed by confocal
microscopy (Figure 5). The fluorescent intensities of GST-GFP
fused with WT and the N46, and RK8AA mutants corresponded
with those of DsRed-ER, indicating that WT, N46, and RK8AA
mutants localized at the ER. In contrast, the fluorescence
intensities of GST-GFP fused with the other mutants did not
correlate with those of DsRed-ER. These observations demon-
strated that the basic amino acid residues of the N-terminal region
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Figure 4. The N-terminus of agnoprotein is necessary for
targeting to the ER. (A) Hydrophobicity plot of JCV agnoprotein. The
plot was drawn using the Lyte-Doolittle method of calculating
hydrophilicity over a window length of seven [54]. (B) The N-terminal
region of agnoprotein is characterized by the presence of positively
charged residues. Schematic representation of GST-EGFP fusion
constructs of wild type (WT) agnoprotein and its various mutants. The
green boxes indicate the basic amino acid clusters, which could be
important for determining the orientation to the membrane. A gray box
indicates a hydrophobic amino acid stretch. (C) Immunoblot analyses of
GST-EGFP–fused agnoprotein and its mutants prepared from the ER-
nuclear fraction of transfected HEK293 cells prepared by sucrose density
centrifugation as described in the Materials and Methods. WT and N46
mutant were detected in the ER-rich fractions, whereas the C6 mutant
and GST-EGFP were not.
doi:10.1371/journal.ppat.1000801.g004
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that agnoprotein is indeed a type II integral transmembrane
protein.
Agnoprotein Forms Homo-Oligomers
Viroporins are responsible for membrane leakiness late in
infection. Typically, viroporins are comprised of some 60–120
amino acids, contain a highly hydrophobic domain, and may also
contain a stretch of basic amino acids. The insertion of viroporins
into membranes is followed by their oligomerization and this is
thought to be critical for membrane destabilization [2] [6].
Agnoprotein is an integral membrane protein that has some of the
expected features of viroporins. To determine whether agnopro-
tein acts as a viroporin, we examined the formation of agnoprotein
homo-oligomers by several methods: 1) coimmunoprecipitation of
epitope-tagged agnoproteins (Figure 6A), 2) chemical cross-linking
of SVG-A cells infected with JCV (Figure 6B), and 3)
intermolecular fluorescence resonance energy transfer (FRET)
studies using agnoprotein fused with either Venus (YFP-Agno) or
sECFP (CFP-Agno) at the NH2-terminus (Figures 6C and D).
Figure 5. The basic amino acids of the N-terminus and hydrophobic region are necessary for the ER targeting. WT, N46, and RK8AA
mutants localized at the ER. Subcellular localization in 293T cells transiently transfected with the constructs described in Figure S3 and pDsRed-ER
were analyzed by confocal microscopy. The boxed areas in the left panel are shown at higher magnification in the right panel. Graphs are relative
fluorescent intensities along the white lines of higher magnification images. The fluorescent intensities of GST-GFP fused with WT, N46, and RK8AA
mutants corresponded with those of DsRed-ER, indicating that WT, N46, and RK8AA mutants localized at the ER. In contrast, the fluorescence
intensities of GST-GFP fused with the other mutants were not in accordance with those of DsRed-ER.
doi:10.1371/journal.ppat.1000801.g005
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tagged agnoprotein using anti-Flag antibody (Figure 6A), suggest-
ing that agnoprotein forms homo-oligomers. SVG-A cells infected
with JCV were incubated with a crosslinker reagent, disuccinimi-
dyl suberate (DSS) or buffer alone, and homogenized with Triton
X-100 containing lysis buffer following immunoblotting. The
immunoblotting revealed that there were multiple bands, which
migrated with the expected positions of monomers (approximately,
8 kDa), dimers (16 kDa), trimers (24 kDa), tetramers (32 kDa),
and pentamers (40 kDa) (Figure 6B). Furthermore, FRET assays
confirmed that agnoprotein forms homo-oligomers at the
cytoplasmic organelles where agnoprotein is known to localize
(Figures 6C and D).
Expression of Agnoprotein Results in Enhanced Plasma
Membrane Permeability
To determine whether agnoprotein is capable of producing
permeabilization of the plasma membrane, we examined plasma
membrane structures using Merocyanine 540 (MC540), which is a
lipophilic fluorescence dye that binds to the outer leaflet of plasma
membranes [34]. Several studies in model membranes have
demonstrated that its fluorescence characteristics are sensitive to
subtle differences in lipid packing [35] [36]. We used flow
cytometry to examine MC540 binding of HeLa cells transfected
with agnoprotein (Agno) or mock plasmid (Mock), or without
transfection (NT). The MC540 intensity in Agno cells was
significantly higher than in Mock or NT cells (Figure 7A),
suggesting that agnoprotein disrupts lipid packing and modifies the
structure of the plasma membrane. To extend these findings, we
performed a Hygromycin B (HygB) permeability assay. HygB is a
general inhibitor of translation, and intact mammalian cells are
impermeable to HygB when exposed for short time periods at low
concentrations. However, HygB will enter mammalian cells with
permeabilized plasma membranes [37]. HeLa cells were trans-
fected with pCFPNLS-Agno or mock plasmid. The plasmid
contains the internal ribosome entry site (IRES) of the encepha-
lomyocarditis virus (ECMV) between the multiple cloning sites
(MCS) and the CFPNLS [sECFP with nuclear localization signal
(NLS) of simian virus 40 large T-antigen fused to its C-terminus]
following the immediate early cytomegalovirus promoter which
permits both the inserted gene in the MCS and the CFPNLS gene
to be translated from a single bicistronic mRNA. The cells
transfected with the plasmids were identified by expression of
sECFP in the nucleus. Following incubation for 72 h, cells were
then radiolabeled with [
35S] Met-Cys for 2 h in the absence or
presence of HygB. Cell extracts were harvested, and the protein
synthesis marker CFPNLS was detected by immunoprecipitation
with an anti-GFP antibody that cross-reacts with CFP. In cells
transfected with pCFPNLS-Agno, radio-labeled CFPNLS levels
were markedly decreased in the presence of HygB; in contrast in
mock transfected cells, CFPNLS levels were unaffected by HygB
(Figures 7B and C). Thus, agnoprotein expression clearly altered
the cell membrane permeability for HygB. This increase in
membrane permeability for HygB was also confirmed using SVG-
A cells (Figure S4A and S6A).
Viral proteins, which can enhance plasma membrane permea-
bilization to small molecules such as HygB, can also induce an
increased permeability to ions, such as Ca
2+ [2] [6]. We measured
the influx of extracellular calcium using the intramolecular FRET-
based Ca
2+ indicator, yellow cameleon 3.60 (YC3.60) [38]. Ca
2+
influx into cells was induced by addition of CaCl2 to the
extracellular medium in the presence, but not in the absence, of
agnoprotein (Figures 7D, E, and F; the video files can be viewed as
supplementary Videos S1 and S2). These studies show an
increased permeability for Ca
2+ and it can be concluded that
agnoprotein enhances membrane permeability to ions as well as to
small molecules.
We also investigated whether agnoprotein possesses inherent
properties that result in cell permeabilization and death indepen-
dent of the signaling pathways within the host organism. To
address this question, the cell permeability of Escherichia coli (E.
coli) was examined after expression of either agnoprotein
containing His tag at the NH2-terminus or VP1 without a His
tag driven by a T7 promoter as has been previously described for
SV40 VP4 [39]. The integrity of the E. coli double-membrane
barrier was analyzed by determining the sensitivity of protein
synthesis to HygB. To inhibit the E. coli RNA polymerase and
prevent the synthesis of endogenous bacterial proteins, rifampicin
was also added during the induction of E. coli growth. The
expression of VP1 had no effect on E. coli membrane
permeability, as the synthesis of
35S-labeled VP1 was not inhibited
by addition of HygB (Figure 7G, left panel, arrow head). In
contrast, agnoprotein expression resulted in the permeabilization
of E. coli, as the synthesis of
35S-labeled agnoprotein was clearly
inhibited in the presence of HygB (Figure 7G, right panel, arrow
head). Cellular membrane permeabilization can lead to cell lysis or
cell death. Therefore, we investigated the viability of E. coli after
the induction of either VP1 or agnoprotein expression to
determine whether these viral proteins possess lytic properties.
The induction of VP1 expression did not cause obvious lysis of the
bacteria, as no decrease in the OD was observed (Figure S4B)
Instead, the induction of agnoprotein showed a relatively low
increase rate of OD compared to that of VP1 (Figure S4B). These
observations indicated that agnoprotein expression does not cause
lysis but would appear to have some toxic effect on E. coli growth.
While the molecular basis of this effect is unclear it may be due to
or be related to the permeabilization of the bacterial membrane.
Arg-8 and Lys-9 are Necessary for the Viroporin Activity
of Agnoprotein
To further investigate the viroporin activity, we performed a
HygB permeability assay with agnoprotein mutants (N46 mutant
and RK8AA mutant), which localize at the ER similar to WT
protein (Figure 5). In N46 mutant- or WT Agno-transfected HeLa
cells, the amount of radio-labeled CFPNLS was markedly
decreased in the presence of HygB compared to its absence
(Figure 8A). In contrast, the levels of CFPNLS were unaltered in
mock or RK8AA- transfected cells (Figure 8A), suggesting that
WT Agno and N46, but not RK8AA, enhances membrane
permeabilization. To further demonstrate the importance of this
viroporin activity, we generated viral genomes containing the
RK8AA mutation of agnoprotein (RK8AAJCV) and performed
JCV growth assays. Viral growth was measured by monitoring the
percentage of VP1 positive cells (Figure 8B). At 3 and 5 days post-
transfection, the percentage of VP1 positive cells were similar in
wtJCV- and RK8AAJCV-transfected cells (Figure 8B). However,
by 9 days the percentage of VP1 positive cells of RK8AAJCV-
transfected cells had significantly decreased compared to that at
day 5, whereas that continued to increase in wtJCV-transfected
cells (Figure 8B), suggesting that RK8AA mutation of agnoprotein
was associated with impaired viral propagation. The amount of
VP1 in the culture supernatant of RK8AAJCV-transfected cells
was, as expected, substantially decreased (SUP in Figure 8C and
S6B). The intracellular localization and expression level of
agnoprotein of RK8AAJCV-transfected cells was similar to those
of wtJCV-transfected cells (Figures S5A and B). These results
suggested that RK8AAJCV has a defect in the release of progeny
virus. Transmission electron microscopy was carried out to
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the virion assembly. This revealed the presence of virus particles of
40-nm in diameter in the nuclei of RK8AAJCV-transfected cells
similar to that observed in wtJCV-transfected cells at 5 days post-
transfection (Figure 8D, left and middle columns). In contrast,
particles were not observed in cells without transfection (Figure 8D,
right columns). The virions extracted from the cells transfected
with RK8AAJCV were able to infect to the SVG-A cells similar to
that of wtJCV and thus were not defective (Figure S5C). These
findings show that the inability of the RK8AAJCV to propagate
viral infection is due to a defect(s) in virion release. Taken together,
Arg-8 and Lys-9 in the NH2-terminus of agnoprotein are
necessary for viroporin activities, which permeabilize the cell
membrane and release virions from the JCV infected cells.
Discussion
In this study, we demonstrate that JCV agnoprotein, which
primarily localizes at the ER, is also present in the plasma
membranes, and that the basic amino acid clusters in the N-
terminus are necessary for its localization. In addition, we have
demonstrated that agnoprotein acts as a viroporin in that it forms
homo-oligomers as an integral membrane protein and that
expression of agnoprotein results in plasma membrane permea-
bilization, which in turn facilitates release of progeny virions.
Moreover we show that Arg-8 and Lys-9 in the NH2-terminus of
agnoprotein are necessary for the viroporin activity.
Agnoprotein is an Integral Membrane Protein, which is
Primarily Distributed to the ER but also Localizes at the
Plasma Membrane
The amino acid sequence of JCV agnoprotein shares ,60%
identity with that of the other polyomaviruses SV40 and BKV. In
contrast the sequences of other viral proteins, such as VP1 or
large T Ag, are highly conserved (80–90% identity). The C-
terminal amino acid sequences of the agnoproteins are unique in
the individual viruses, whereas those at the N-terminal 40 amino
acids exhibit around 90% identity. As the subcellular localizations
of the agnoproteins are almost identical, this suggests the
existence of a functional domain in the N-termini. JCV
agnoprotein is the only viral transcript expressed in cytoplasm
rather than the nucleus, and especially in perinuclear region [20].
In contrast to the other viral late proteins, agnoprotein is not
incorporated into in the viral capsid and is undetectable in
purified infectious virions.
In this report we demonstrate that JCV agnoprotein is an
integral transmembrane protein type II targeted to the organelles
in an exocytic route, involving the ER and subsequently localizing
to the plasma membrane in time-dependent manner. The integral
transmembrane protein type II agnoprotein has a cytoplasmic
amino terminus and an extracellular carboxyl terminus [32].
Positively charged amino acids at the N-terminal region are
important for determining the orientation of the transmembrane
segment [33]. In the N-terminus of agnoprotein, there are several
positively charged amino acids, and these residues with the
exception of Arg-8 and Lys-9 contribute to the subcellular
localization of the protein.
Agnoprotein Forms Homo-Oligomers and Increases
Membrane Permeabilization
Viruses produce a number of injuries during infection of
susceptible cells. Some of these affect cell membranes, and a
typical feature observed during the replication of a number of
animal viruses is enhanced membrane permeability. Several viral
gene products are considered to be responsible for these changes
and these include proteases, glycoproteins, and viroporins [2] [6].
Viroporins are small, highly hydrophobic, virus-encoded proteins
that interact with membranes modifying the cell permeability to
ions or other small molecules. Typically, viroporins are comprised
of some 60–120 amino acids and contain a highly hydrophobic
domain. The insertion of viroporins into membranes followed by
their oligomerization leads to membrane destabilization, thus
enhancing permeability [2] [6]. We have found that agnoprotein
has all of the features of viroporins and is capable of enhancing the
membrane permeability for Hygromycin-B and Ca
2+. In addition,
agnoprotein enhanced the plasma membrane binding of MC540
which is a lipophilic fluorescence dye binding to the outer leaflet of
plasma membranes [34]. While the changes of binding of MC540
support alterations of membrane structures, the studies do not
allow clear definition of any particular mechanism [40]. Our
results also show that agnoprotein can permit small molecules
[molecular weight (MW) under 1,000 Da] to enter the cytoplasm.
Because the MW of virions are much larger than 1,000 Da, they
may be released from the cells not through the direct effect of
membrane permeabilization but perhaps indirectly by the
alteration of cytoplasmic concentrations of monovalent cations,
which can provoke membrane depolarization, leading to cell lysis
[7]. In SV40, VP2 and VP3, but not VP1, possess membrane-
permeabilizing activity in prokaryotic cells [41]. Furthermore, the
ability to induce bacterial lysis following permeabilization was an
exclusive property of VP3, suggesting that membrane permeability
changes induced by VP3, and perhaps VP2 as well, are largely
responsible for the necrosis resulting from SV40 infection and that
the lytic activity of VP3 may be necessary for the release of
progeny virions [41]. In this study we also show that JCV
agnoprotein possesses bacterial membrane-permeabilizing activity.
However, agnoprotein could not induce bacterial lysis. Thus, is
Figure 7. Agnoprotein impairs membrane integrity. (A) HeLa cells were transfected with pCXSN-Agno (Agno) or pCXSN (Mock) and assayed by
flow cytometry for MC540 binding. NT: not transfected. (B) HeLa cells were either transfected with control vector (Mock) or pCFPNLS-Agno (Agno) for
72 h. The cells were pretreated with or without HygB (400 mg/ml), radiolabeled with [
35S] Met-Cys, and incubated in the absence (+) or presence (2)
of HygB for 2 h. The cell extracts were harvested, and the marker protein was immunoprecipitated with an anti-GFP antibody and analyzed by SDS-
PAGE. (C) The results of (B) were quantified by Image Gauge V3.2 software. The bar graph represents the protein synthesis ratio in the presence to the
absence of HygB, and corresponds to an average of triplicates 6 S.D. Significance was analyzed by Student’s t-test and is indicated by asterisk
(*p,0.01). (D) Intracellular Ca
2+ concentration was measured by an intramolecular FRET-based Ca
2+ indicator. HeLa cells were transfected with FRET
probe (YC3.60) and coexpressed pERedNLS-Agno (Agno) or pERedNLS (Mock). Permeability to Ca
2+ in agnoprotein (Agno)- or mock (Mock)-expressed
cells was evaluated by the change in FRET ratio induced by the addition of 5 mM CaCl2 to the extracellular medium at 100 sec after the start of
recording. Results of cells with agnoprotein or mock are the mean 6SD from 28 or 39 cells, respectively. (E) The bar graph represents the highest
FRET ratio at 69500 (*p,0.001). (F) Ratio images of FRET/CFP were created to represent FRET efficiency. The upper (4.5) and lower (2.6) limits of the
ratio range are shown at the bottom. (G) Agnoprotein permeabilizes bacterial cells. E. coli cultures were pulsed for 10 min with [35S]Met-Cys in the
absence or presence of hygromycin B with or without inducing the expression of VP1 (left panel) or Agno with a NH2-terminal His tags (His-Agno,
right panel) with IPTG. Rifampicin was included during the induction to inhibit endogenous E. coli protein synthesis. Bacteria were sedimented, lysed,
and resolved by 4–12% reducing SDS-PAGE followed by autoradiography.
doi:10.1371/journal.ppat.1000801.g007
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Figure 8. ‘‘RK’’ residues of Agnoprotein are necessary for viroporin activity. (A) HygB permeability assays with HeLa cells transfected
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concentrated to 25 times by centrifugation. (D) Electron microscopic analysis of wtJCV- or RK8AAJCV–transfected SVG-A cells. NT: not transfected.
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doi:10.1371/journal.ppat.1000801.g008
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proteins in addition to agnoprotein during JCV infection.
Arg-8 and Lys-9 of Agnoprotein Define the Viroporin
Activity
Some viroporins contain a stretch of basic amino acids that act
as a detergent [6] and agnoprotein has some clusters of basic
residues in the NH2-terminal 24 amino acids. The R4A and
KKR22AAG mutants of agnoprotein did not distribute to the ER,
suggesting that these residues are important for the correct
intracellular localization of agnoprotein. Although the RK8AA
mutant of agnoprotein localized at the ER as well as WT, this
mutant did not have the viroporin activity. These observations
indicate that the ‘‘RK’’ residues at amino acid positions 8 and 9 of
agnoprotein are not necessary for the intact intracellular
localization but contribute to the plasma membrane permeability.
These residues may serve as a detergent, modify the membrane
structure, or interact with other molecules in host cells. However,
the exact functions of these basic amino acids will further
investigation and these studies will certainly help elucidate the
molecular mechanisms of the viroporin activity.
Furthermore, previous studies with other polyomaviruses have
implied a direct interaction of agnoprotein and VP1 [42], and
indeed JCV agnoprotein does interact with GST-fused VP1
synthesized in E. coli [our unpublished observation]. These
interactions would appear to be in addition to the role of
agnoprotein as a viroporin. Thus agnoprotein can be considered
to be a multifunctional auxiliary protein [43], and studies on other
polyomavirus agnoproteins have suggested that the protein may
contribute to a variety of stages of the viral life cycle including
assembly of virions and viral propagation [14] [16] [17] [18] [19].
Thus, the function of agnoprotein and the interaction with VP1
will require further investigation to clarify the roles of JCV
agnoprotein in virion assembly.
In summary, our studies demonstrate that agnoprotein acts as a
viroporin resulting in plasma membrane permeabilization and
virion release. The permeabilization induced by agnoprotein is
crucial for viral propagation and could be a potential target for a
therapeutic intervention in PML. Furthermore, our study
highlights that the mechanism of virion release of a non-enveloped
DNA virus is highly regulated by a single viral protein.
Materials and Methods
Construction of Plasmids
For expression of JCV agnoprotein in mammalian cells, the cDNA
of JCV agnoprotein was amplified by polymerase chain reaction (PCR)
using a plasmid encoding the JCV genome, pJC1-.4pJCV [VG015,
Health Science Research Resources Bank (HSRRB)] and subcloned
into a pGST-EGFP plasmid including GST into the Kpn I and Bam
HI sites of pEGFP-N1 (Clontech Mountain View, CA); pCXSN
plasmid which was constructed by removing myc-tag from pCMV-
myc (Clontech) and adding Xho I, Sal I, and Not I recognition sites;
pCXSN-FlagN which was constructed by adding Flag-tag to pCXSN
plasmid at the 59 region of Xho I site; pCXSN-MycN which was
constructed by adding Myc-tag to pCXSN plasmid at the 59 region of
X h oIs i t e ;p E R e d N L S( k i n d l yp r o v i d e db yD r .M .M a t s u d a ) ;a n d
pCFPNLS which was constructed by replacing DsRedExpress with
sECFP (kindly provided by Dr. A. Miyawaki); pCXSN-YFP/CFP
which constructed by insertion of Venus (kindly provided by Dr. A.
Miyawaki) or sECFP to the Xho I site of pCXSN and adding linker
sequences (RSTGNSADGGGGSGGSGGSGGGSTQGGSSGTG-
TAAENSGNSRTK) at the 39 region of Venus or sECFP. Deletion
mutants of agnoprotein were constructed by PCR with KODplus
polymerase (Toyobo, Tokyo, Japan). The substitution mutants of
agnoprotein were constructed by using the QuickChange site-directed
mutagenesis kit (Stratagene) according to the manufacture’s procedure.
The primers used for generating mutants of agnoprotein were (59 -.
39): 1, ctcagatctaatggttcttGCCcagctgtcacg and ctggtaccgtagcttttggtt-
caggcaaagc (R4A); 2, ctcagatctaatggttcttcgccagctgtcaGCTGCTgct
and ctggtaccgtagcttttggttcaggcaaagc (RK8AA); 3, gtaaaacctggagtg-
gaactGCAGCAGGAgctcaaaggatttta and taaaatcctttgagcTCCTGC-
TGCagttccactccaggttttac (KKR22AAG). The following plasmids
containing wild type (WT) agnoprotein were used as PCR templates:
pGST-EGFP-Agno, pCXSN-Agno, and pERedNLS-Agno. The
plasmid containing the genome of JCV Mad1-SVED (pUC19-
Mad1SVED) was kindly provided by Dr. W. J. Atwood [28] [44].
Agnoprotein with mutated viral genomes (DAgno and RK8AA) were
generated by site-directed mutagenesis using PCR with pUC19-
Mad1SVED, which has WT agnoprotein, and KODplus polymerase.
In the DAgno mutant, the translation initiation codon (ATG) of
agnoprotein was changed to the stop codon (TAA) by base substitution,
and the DAgno mutant viral DNA is defective in the production of
agnoprotein. Primers used for mutagenesis were (59-. 39): 1,
TAAgttcttcgccagctgtcacg and ggccagcggtacctgtggaat (DAgno). 2,
GCTgctttctgtgaaagttagtaaaacctgg and AGCtgacagctggcgaagaaccatg
(RK8AA). Mismatched nucleotides are shown in uppercase letters.
Successful mutagenesis was confirmed by sequencing. A DsRed-ER
expressing plasmid (pDsRed-ER) was obtained from Clontech. All the
constructs and materials used in the experiments were described in
Table S1.
Cell Culture and Virus preparation
Human embryonic kidney 293 cells with SV40 T antigen
(HEK293T), human cervical carcinoma cells (HeLa), and human
neuroblastoma cells IMR-32 cells were obtained from the
HSRRB. A JCV-producing cell line (JCI cells [45]) and SV40-
transformed human glial SVG-A cells (kindly provided by Dr. W.
J. Atwood) [46] were also used. All cells were maintained under
5% CO2 at 37uC condition in Dulbecco’s minimal essential
medium (DMEM) supplemented with 10% heat-inactivated fetal
bovine serum (FBS), 2 mM L-glutamine, penicillin, and strepto-
mycin (Sigma). Establishment and maintenance of HEK293 cells
expressing JCV agnoprotein in an inducible manner (293AG cells)
was described previously [22] [23].
For virus preparation, JCI cells or JC virus-infected SVG-A cells
were harvested and suspended in Tris-HCl (pH 7.5) containing
0.2% bovine serum albumin (BSA), frozen and thawed three
times, and then treated with 0.05 U/ml of neuraminidase type V
(Sigma) at 37uC for 16 h. After incubation at 56uC for 30 min, cell
lysates were centrifuged at 1,0006g for 10 min. The supernatant
was quantified by hemagglutination (HA) assays and stored at
280uC until use.
Primary Antibodies
Rabbit anti-JCV agnoprotein, anti-JCV VP1, and anti-JCV
Large T polyclonal antibodies were produced as described
previously [47] [20] [48]. Alexa 594–labeled anti-agnoprotein
antibody was used for double-immunofluorostaining with another
rabbit polyclonal antibody. Mouse anti-BiP and anti-Calnexin
monoclonal antibodies were purchased from BD Transduction
Laboratories. Mouse anti-actin (MAB1501R) monoclonal anti-
bodies were purchased from Chemicon International. Mouse anti-
Flag (M2) and anti-alpha tubulin monoclonal antibodies were
purchased from Sigma. Goat anti-GFP polyclonal antibody was
purchased from Rockland. Rabbit anti-calreticulin polyclonal
antibody was purchased from Calbiochem.
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Mutant and WT viral DNA were linearized at the Bam HI site,
and equal amounts of viral DNA were transfected into permissive
SVG-A cells by Fugene HD (Roche Diagnostics) reagents
according to the manufacturer’s instructions. Viral growth at the
indicated time points was monitored by indirect immunofluores-
cence of VP1. For quantification of viral particle release, the
culture supernatant was collected at each indicated time point and
ultracentrifuged in a Beckman TLA-100.3 rotor at 80,000 rpm for
60 min at 4uC. The pellet fraction and whole cell lysates (WCL)
were analyzed simultaneously by immunoblotting. Results were
confirmed by at least three independent experiments.
Confocal Microscopy
Cells were fixed with 3% paraformaldehyde (PFA) in phos-
phate-buffered saline (PBS), permeabilized with 0.5% Triton X-
100 in PBS, and incubated at room temperature with 1% BSA in
PBS. The cells were then incubated with primary antibodies,
followed by Alexa 488– or Alexa 594–labeled goat antibodies to
rabbit IgG or with Alexa 488– or Alexa 594–labeled goat
antibodies to mouse IgG (Molecular Probes). The cells were
observed with a confocal laser-scanning microscope (Olympus,
Tokyo, Japan).
For analysis of colocalization between GST-EGFP proteins and
DsRed-ER, the 293T cells transfected with pGST-EGFP-Agno or
mutant plasmid and pDsRed-ER were fixed with 3% PFA in PBS
at 48 h post-transfection. The cells were then observed with a
confocal laser-scanning microscope. The fluorescence intensity
along a white straight line of the captured images was measured by
using FV10-ASW ver.1.6 imaging software (Olympus). Cell
surface immunofluorescent staining was previously described
[49]. Briefly, cells were incubated in DMEM with 10% fetal calf
serum and an appropriate primary antibody for 1 h at 4uC. After
washing three times with cold PBS, the cells were fixed with 3%
PFA and then stained with Alexa488-conjugated anti-mouse IgG
antibody.
Analysis of the Association of Proteins with Membranes
Microsome fractions were prepared essentially as described
previously [30]. Briefly, 293AG cells in five 10 cm-diameter dishes
were homogenized with a Dounce homogenizer in 5 ml of
homogenizing buffer (0.25 M sucrose and 20 mM Hepes-NaOH)
supplemented with Complete protease inhibitor cocktail (Roche).
The homogenate was centrifuged at 1,0006g for 10 min at 4uC.
The supernatant was centrifuged at 2,0006g for 30 min at 4uC.
The supernatant was then ultracentrifuged in a Beckman TLA-
100.3 rotor at 85,000 rpm for 30 min at 4uC. The pellet
(microsomes) and the supernatant (cytosol) fractions were mixed
with an equal volume of 2 6 SDS-PAGE sample buffer and
analyzed by immunoblotting.
To analyze the association of proteins with membranes, the
pellet fraction (microsomes) were further incubated with 100 mlo f
1 M KCl, 0.2 M sodium carbonate (pH 11), or 2 M Urea in the
buffer for 1 h on ice and then recovered by ultracentrifuging in a
Beckman TLA-100.3 rotor at 85,000 rpm for 30 min at 4uC. The
supernatant and pellet fractions were then analyzed by immuno-
blotting. Triton X-114 phase separation was performed as
described previously [30]. Briefly, the microsomes thus prepared
were incubated in the Tx114-lysis buffer [1% Triton X-114,
10 mM Tris-HCl (pH 7.4), 150 mM NaCl, and 1 mM EDTA]
with Complete protease inhibitor cocktail for 60 min at 4uC. The
lysate was centrifuged at 10,0006g for 15 min at 4uC. The
supernatant was incubated at 37uC for 3 min and then centrifuged
at 10,0006g for 1 min at 4uC. The upper (aqueous) phase, the
lower (detergent) phase and the pellet were analyzed by
immunoblotting.
Iodixanol Density Gradient Analysis
In order to analyze the membranous fraction from JCI cells,
cells in a 10 cm-diameter dish were suspended in 1 ml of the
homogenization buffer A [0.25 M sucrose and 60 mM HEPES-
NaOH (pH 7.4)] containing protease inhibitor (Complete Mini,
EDTA-free, Roche Diagnostics). The cells were homogenized
using a tight-fitting Dounce homogenizer (5 strokes), and the
homogenates were centrifuged at 4006g for 3 min to remove the
nuclei and cell debris. The supernatant was treated with a solution
containing 20 mg/ml DNase I, 7.5 mM manganese chloride, and
0.5 mM DTT for 30 min at room temperature, and centrifuged at
13,0006g for 15 min at 4uC. The pellets were resuspended with
2 ml of the homogenization buffer B [0.25 M sucrose, 1 mM
EDTA, and 10 mM HEPES-NaOH (pH 7.4)], and immediately
used for fractionation. Iodixanol (OptiPrep, Nycomed) density
gradient analysis was performed according to the manufacturer’s
instructions. A working solution of 50% iodixanol [5:1 v/v mixture
of OptiPrep and 0.25 M sucrose, 6 mM EDTA, 60 mM HEPES–
NaOH (pH 7.4)] was diluted with the homogenization buffer to
prepare a 25% solution. Iodixanol continuous gradients were
formed with 5.5 ml each of 0% (the homogenization buffer
containing the protease inhibitor) and 25% iodixanol solutions in
13-ml open-top centrifuge tubes. Two ml of the cell lysates was
overlaid on the top of the gradients, and then ultracentrifuged in a
Hitachi P40ST rotor at 40,000 rpm for 2.5 h at 4uC. The
gradients were fractionated into 24 fractions of each 500 ml from
the top, and analyzed by immunoblotting.
Quantification of the intensities of obtained bands by immuno-
blotting was performed using the Image Gauge V3.2 software (Fuji
Film, Tokyo, Japan).
Flow Cytometry
293T cells were detached using an enzyme-free/PBS-based cell
dissociation buffer (Gibco/BRL) according to the manufacturer’s
instruction. Aliquots of 10
6 cells were washed in PBS/2% FBS and
suspended in 100 ml of PBS/2%FBS. Cells were then incubated
with 200 ng of primary antibody or control IgG (BD Pharmingen)
as a negative control for 30 min at 4uC. After washing, bound
antibodies were visualized by addition of phycoerythrin (PE)-
conjugated anti-mouse or -rabbit Ig antibody (Beckman Coulter).
After washing, cells were suspended in 250 ml of PBS/2% FBS.
Cell surface fluorescence was analyzed with a Becton Dickinson
FACScalibur (BD Bioscience, San Jose, California).
Transfection, Immunoblot Analysis, and
Immunoprecipitation
Cell transfection was performed with Lipofectamine 2000
(Invitrogen) for 293T cells or Fugene HD for HeLa and SVG-A
cells. For immunoblot analysis, cells were harvested at the
indicated time points after transfection, lysed in TNE buffer
[10 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 10%
glycerol, 1% Triton X-100, and 0.5 mM phenylmethylsulfonyl
fluoride (PMSF)], and mixed with Complete protease inhibitor
cocktail. The cell lysates were fractionated by SDS-PAGE, and the
separated proteins were transferred to a polyvinylidene difluoride
filter (Millipore). The filter was incubated with primary antibodies,
and immune complexes were then detected with horseradish
peroxidase–conjugated secondary antibodies and ECL reagents
(GE Healthcare). The Flag epitope was detected directly with
horseradish peroxidase–conjugated primary antibodies.
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cells transfected with Myc-tagged agnoprotein/Flag-tagged agno-
protein or Myc-tagged agnoprotein alone were incubated for 72 h
and then lysed in TNE buffer and subjected to immunoprecip-
itation.
Immunoprecipitation was performed by incubation of cell
lysates at 4uC first for 4 h with antibody-coupled protein G–
Sepharose FF beads (GE Healthcare). After washing with cell lysis
buffer, the bead-bound proteins were subjected to immunoblot
analysis.
Preparation of an ER-Nuclear Fraction
Subcellular fractionation was performed by a procedure that
allows separation of nuclei and ER from other membrane
fractions. Cells were suspended in ice-cold sucrose buffer I
[0.32 M sucrose, 3 mM CaCl2, 2 mM magnesium acetate,
0.1 mM EDTA, 10 mM Tris-HCl (pH 8.0), 1 mM dithiothreitol
(DTT), and 0.5% Nonidet P-40] and then mixed with sucrose
buffer II [1.8 M sucrose, 5 mM magnesium acetate, 0.1 mM
EDTA, 10 mM Tris-HCl (pH 8.0), and 1 mM DTT]. The
resulting mixture was gently overlaid on 4.4 ml of sucrose buffer
II in a 13-ml open-top centrifuge tube to form a discontinuous
sucrose gradient. The gradient was centrifuged at 30,0006g for
45 min at 4uC, and the resulting pellet was washed with PBS
containing 0.5% Triton X-100. The pellet was then lysed in
nuclear lysis buffer [25 mM Tris-HCl (pH 7.4), 300 mM NaCl,
0.5% Nonidet P-40, and 0.5% sodium deoxycholate] and rotated
for 1 h at 4uC. The lysate was centrifuged at 20,0006g for 30 min
at 4uC, and the resulting supernatant was subjected to immunoblot
analysis.
Chemical Cross-Linking
Crosslinking of agnoprotein in SVG-A cells infected with JCV
was performed as described previously with minor modifications
[50]. SVG-A cells infected with JCV for 1 week were detached
using an enzyme-free/PBS-based cell dissociation buffer (Gibco/
BRL) according to the manufacturer’s instruction. Aliquots of 10
6
cells were washed in DPBS (+) and suspended in 100 ml of PBS/
2% FBS. The cells were suspend in 100 ml of DPBS (+) and then
reacted with 0.5, 1, 2 or 5 mM disuccinimidyl suberate (DSS,
Pierce) or DMSO for 2 h at 4uC. The cells were quenched with
50 mM Tris (pH 7.5) for 30 min at 4uC and then lysed in 1%
Triton X-100 in PBS at 4uC and centrifuged at 15,0006g for
15 min at 4uC. Supernatants were subjected to SDS-PAGE and
immunoblot analysis using anti-agnoprotein antibody.
Intermolecular FRET Signal Correction and Normalization
The method of analyzing the oligomerization of agnoprotein was
adapted from a previously published method [51]. SVG-A cells
plated on collagen-coated 35-mm diameter glass base dishes (Asahi
Techno Glass, Tokyo, Japan) were transfected with pCXSN-YFP-
Agno/pCXSN-CFP-Agno or pCXSN-YFP/pCXSN-CFP. The
cells were then placed in a chamber box on a microscope, in which
the temperature was maintained at 37uC, and were imaged with an
IX71 inverted microscope (Olympus), as described previously [52].
The analysis of the cell image data, FRET signal correction and
normalization was conducted as reported previously [51].
Measurement of Lipid Packing of Plasma Membrane
The lipid packing of plasma membrane can be studied by
inserting the fluorescence probe, MC540 (Sigma) into cell
membranes and assessing the degree of insertion by fluorescence
intensity measurement using flow cytometry [34] [35]. HeLa cells
were transfected with pCXSN-Agno or pCXSN vector, and were
incubated for 72 h. The cells were then detached by using an
enzyme-free/PBS-based cell dissociation buffer. The cells were
suspended in 10 mg/ml MC540/DPBS (+). After 10 min
incubation at 37uC, cells were washed in DPBS (+). After
washing, cells were suspended in 250 mlo fD P B S( +). Cell surface
fluorescence was analyzed with a Becton Dickinson FACScalibur.
FACScalibur wasused at 488 nmexcitationand 575 nmemission
wavelengths.
Hygromycin B (HygB) Permeability Assay
Permeability of the plasma membranes of agnoprotein-trans-
fected cells to HygB (Clontech) was determined as described
previously [37]. Briefly, HeLa cells or SVG-A cells were plated on
a 35-mm dishes and transfected with pCFPNLS-Agno, pCFPNLS-
N46, pCFPNLS-RK8AA, or pCFPNLS. At 72 h post-transfec-
tion, the cells were pretreated with HygB (400 mg/ml) for 15 min,
and then 50 mCi of [
35S] Met-Cys were added to the culture
medium. The cells were then incubated at 37uC for 2 h in the
presence or absence of HygB. The cell extracts were lysed in
500 ml of RIPA buffer mixed with protease inhibitor and subjected
to immunoprecipitation with goat anti-GFP antibody-coupled
protein G-Sepharose FF beads. The bead-bound proteins were
analyzed by SDS-PAGE and autoradiography.
Determination of Ca
2+ Influx into Cells
The method of analyzing the rate of Ca
2+ influx was adapted
from a previously published method [38]. HeLa cells plated on a
collagen-coated 35-mm diameter glass base dish were transfected
with pERedNLS-Agno/pERedNLS and a FRET-based fluores-
cence indicator for Ca
2+, YC3.60 (kindly provided by Dr. A.
Miyawaki). After 96 h, cells were washed once in the recording
medium [10 mM Hepes-NaOH (pH 7.4), 140 mM NaCl, 5 mM
KCl, 1 mM MgCl2, and 0.55 mM Glucose]. The cells were
incubated with the calcium chelater dimethyl-BAPTA-AM
(Molecular Probes) for 30 min at 37uC to prolong the linear
phase of unidirectional Ca
2+ uptake. The cells were then placed in
a chamber box on a microscope, in which the temperature was
maintained at 37uC, and were imaged with an IX71 inverted
microscope, as described previously [52]. Fluorescent images of
CFP and FRET were recorded every 10 sec. At 100 sec, 5 mM
CaCl2 was added to the cells. MetaMorph software (Universal
Image) was used for control of the CCD camera and the filter
wheels, and also for the analysis of the cell image data.
Bacterial Expression Plasmids, E. coli Membrane
Permeability, and Viability
Assays for E. coli membrane permeability and viability have
been previously described [41]. The entire coding sequences of
VP1 (pET15b-VP1) [53] and agnoprotein (pET15b-His-Agno)
were amplified by PCR and cloned into the pET15b expression
vector (Novagen, Madison, WI). The integrity of vectors were
verified by sequencing and transformed into the E. coli BL21
strain (DE3: pLysS) for protein expression (Novagen). For
permeability assays, cultures were grown in the presence of
100 mg/ml ampicillin at 37uC to an optical density (OD) at
590 nm of ,1.0, and protein expression was induced with 1 mM
isopropyl-b-D-thiogalactopyranoside (IPTG) for 10 min prior to
the addition of rifampicin (150 mg/ml) to inhibit transcription of
endogenous genes by the E. coli RNA polymerase. Samples were
incubated for an additional 30 min followed by a 10-min pulse
with 50 mCi [35S] Met-Cys in the absence or presence of 250 mg/
ml hygromycin B. Bacterial cell lysis was monitored by following
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590 nm of ,0.20 was induced by the addition of 1 mM IPTG.
Electron Microscopy
Electron microscopy of JCV-infected cells was performed as
follows: Cells were fixed in 2.5% glutaraldehyde (TAAB,
Aldermaston, UK) in 0.1 M phosphate buffer (PB, pH 7.4) for
48 h at 4uC. Thereafter, cells were washed in the same buffer
containing 7% sucrose, post-fixed in 1% osmium tetroxide (Merck,
Darmstadt, Germany) in 0.1 M PB for 1.5 h at room temperature,
dehydrated in graded acetones, and embedded in Epon (TAAB).
Ultrathin sections (0.1 mm in thickness) were stained with 1.5%
uranyl acetate for 20 min and 0.2% lead citrate for 15 min, and
were examined under an H-7100 electron microscope (Hitachi,
Tokyo, Japan).
Statistical Analysis
All data were expressed as mean 6 S.D. Student’s t-test was
used to analyze differences between two groups. A value of p,0.05
was considered as statistically significant.
Supporting Information
Figure S1 The subcellular localization of VP1 was not affected
by deletion of agnoprotein. SVG-A cells transfected with wtJCV
genome or DAgnoJCV genome were fixed 4 days post-transfection
and immunostained using anti-VP1 antibody followed by Alexa
488-labeled goat anti-rabbit IgG. The cells were then immuno-
stained with Alexa 594-labeled anti-agnoprotein antibody. Local-
ization of VP1 in the cells was analyzed by confocal microscopy.
Scale bars, 20 mm.
Found at: doi:10.1371/journal.ppat.1000801.s001 (4.26 MB EPS)
Figure S2 The amount of agnoprotein expression resulting from
expression vector transfection is similar to that observed after
infection or transfection with the JCV genome. (A) Cell lysates
from SVG-A cells, SVG-A cells infected with JCV, and SVG-A
cells transfected with pCXSN-Agno were analyzed by immuno-
blotting with an anti-agnoprotein antibody, and actin was used as
an internal control. The level of agnoprotein expression in cells
transfected with a plasmid encoding agnoprotein was similar to
that in cells infected with JCV. (B) Cell lysates from SVG-A cells
transfected with wtJCV at the indicated days post-transfection and
cells transfected with pERedNLS (Mock), pERedNLS-Agno, and
pCFPNLS-Agno were analyzed by immunoblotting with an anti-
agnoprotein antibody, and actin was used as an internal control.
The level of agnoprotein expression in cells transfected with a
plasmid encoding agnoprotein was similar to that in cells
transfected with the JCV genome (wtJCV). The intensity of
obtained bands in (A) and (B) was quantified using Image Gauge
V3.2 software (Fujifilm, Tokyo, Japan).
Found at: doi:10.1371/journal.ppat.1000801.s002 (0.79 MB EPS)
Figure S3 Schematic representation of the wild-type and mutant
agnoprotein constructs used in Figure 5. The N-terminal region of
agnoprotein is characterized by the presence of positively-charged
residues. The schematic represents GST-EGFP fusion constructs
of wild-type (WT) agnoprotein and various mutants. The green
boxes indicate the basic amino acid clusters, which could be
important for determining the orientation to the membrane. A
gray box indicates a hydrophobic amino acid stretch.
Found at: doi:10.1371/journal.ppat.1000801.s003 (0.39 MB EPS)
Figure S4 Agnoprotein enhances the membrane permeability
for HygB. (A) SVG-AG cells, which are agnoprotein-inducible
with doxycycline (DOX) treatment, were established using the
Retro-X
TM Tet-On Advanced Inducible Expression System
(Clontech). SVG-AG cells were incubated with or without 1 mg/
ml DOX for 72 h. Nascent protein synthesis in these cells with
HygB at the indicated concentrations was quantified using Click-
iT AHA Alexa Fluor 488 Protein Synthesis Kit (Invitrogen) and
FACScanto (BD Bioscience). (B) E. coli viability was monitored
following the induction of VP1 and His-agnoprotein expression.
Found at: doi:10.1371/journal.ppat.1000801.s004 (1.26 MB EPS)
Figure S5 Comparison of wtJCV and RK8AAJCV. (A) wtJCV-
or RK8AAJCV-transfected SVG-A cells were fixed at 4 days after
transfection. The cells were immunostained using anti-agnoprotein
antibody followed by Alexa 594-labeled goat anti-rabbit IgG and
analyzed by confocal microscopy. Localization of agnoprotein in
cells transfected with RK8AAJCV was similar to that in cells
transfected with wtJCV. (B) wtJCV- or RK8AAJCV-transfected
SVG-A cells were harvested and lysed 4 days after transfection.
Immunoblot analysis was performed with antibodies to agnopro-
tein and actin. The level of agnoprotein expression in cells
transfected with RK8AAJCV was similar to that in cells
transfected with wtJCV. (C) The infectivity of virus extracted
from wtJCV- or RK8AAJCV-transfected cells (cell-associated
virus) was examined by the infection assay in SVG-A cells. Four
days after inoculation with cell-associated virus, the cells were
subjected to immunofluorescent analysis using anti-VP1 antibody.
The cells were visualized with Alexa Fluor 594-conjugated goat
anti-rabbit IgG. After cell nuclei were counterstained with DAPI,
immunofluorescent images were visualized by confocal microscope
FV1000 (Olympus). JCV VP1 was observed in cells infected by
virus isolated from both wtJCV- and RK8AAJCV-transfected
cells, suggesting that the generated virus is infectious and not the
defective RK8AAJCV mutant.
Found at: doi:10.1371/journal.ppat.1000801.s005 (1.64 MB EPS)
Figure S6 Trans-expressed agnoprotein complements virus
release by viroporin-deficient virus. (A) SVG-AG cells, which are
agnoprotein-inducible with doxycycline (DOX) treatment, were
transfected with DAgnoJCV genome and incubated for 72 h. The
cells were then incubated with or without DOX for another 48 h.
Whole cell lysates (WCL) and culture supernatants (SUP) from the
cells were analyzed by immunoblotting with anti-VP1, anti-
agnoprotein, and anti-actin antibodies. The amount of VP1 in the
culture supernatant from cells treated with DOX was substantially
increased compared to those without DOX, which is consistent
with the presence of agnoprotein and suggests that trans-expressed
agnoprotein complements virus release by agnoprotein-deficient
JCV. (B) SVG-A cells stably expressing either N46, which
possesses viroporin activity, or RK8AA, an agnoprotein mutant
which lacks viroporin activity, were transfected with RK8AAJCV
genome and incubated for 5 days. Whole cell lysates (WCL) and
culture supernatants (SUP) from the cells were analyzed by
immunoblotting with anti-VP1and anti-actin antibodies. The
amount of VP1 in the culture supernatant from the cells expressing
N46 was substantially increased compared to that of RK8AA or
Mock cells, suggesting that trans-expressed viroporin complements
virus release of viroporin-deficient JCV.
Found at: doi:10.1371/journal.ppat.1000801.s006 (0.61 MB EPS)
Table S1 Constructs and materials used in the experiments.
Found at: doi:10.1371/journal.ppat.1000801.s007 (0.07 MB PDF)
Video S1 HeLa cells transfected with pERedNLS-Agno and
FRET probe (YC3.60). Cells coexpressing pERedNLS-Agno
(Video S1) or pERedNLS (Video S2) and YC3.60 were incubated
for 72 h. Permeability to Ca
2+ in agnoprotein-expressing (Video
S1) or mock-transfected (Video S2) cells was evaluated by the
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the extracellular medium 100 sec after the start of recording.
Fluorescent images of CFP and FRET were recorded every 10 sec
for 15 min. Ratio images of FRET/CFP were created to represent
FRET efficiency. In the IMD mode shown here, eight colors from
red to blue are used to represent the FRET/CFP ratio. The upper
(red) and lower (blue) limits of the ratio range are 4.5 and 2.6,
respectively.
Found at: doi:10.1371/journal.ppat.1000801.s008 (3.58 MB
MOV)
Video S2 HeLa cells transfected with pERedNLS and FRET
probe (YC3.60).
Found at: doi:10.1371/journal.ppat.1000801.s009 (2.48 MB
MOV)
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